These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9408214)

  • 1. Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test.
    Lopes T; Neubauer P; Boje KM
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1059-64. PubMed ID: 9408214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
    Peterson SL; Purvis RS; Griffith JW
    Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex.
    Nowak G; Li Y; Paul IA
    J Neural Transm (Vienna); 2000; 107(2):123-31. PubMed ID: 10847554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.
    Fossom LH; Basile AS; Skolnick P
    Mol Pharmacol; 1995 Dec; 48(6):981-7. PubMed ID: 8848014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inactivity of imipramine in the forced swimming test on old mice or on young mice undergone chronic glycinergic treatment].
    Vamvakides A
    Ann Pharm Fr; 1996; 54(6):260-2. PubMed ID: 9008899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-cycloserine on extinction: consequences of prior exposure to imipramine.
    Werner-Seidler A; Richardson R
    Biol Psychiatry; 2007 Nov; 62(10):1195-7. PubMed ID: 17555721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.
    Sheinin A; Shavit S; Benveniste M
    Neuropharmacology; 2001 Aug; 41(2):151-8. PubMed ID: 11489451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels.
    Wu SL; Hsu LS; Tu WT; Wang WF; Huang YT; Pawlak CR; Ho YJ
    Behav Brain Res; 2008 Mar; 187(2):246-53. PubMed ID: 17959260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats.
    Pitkänen M; Sirviö J; MacDonald E; Ekonsalo T; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):133-44. PubMed ID: 8526998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression.
    Papp M; Moryl E
    Eur J Pharmacol; 1996 Dec; 316(2-3):145-51. PubMed ID: 8982680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wojcik E
    Neuropharmacology; 1997 Jan; 36(1):31-7. PubMed ID: 9144639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycineB receptors.
    Przegaliński E; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1999 Nov; 64(3):461-6. PubMed ID: 10548256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
    Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
    Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
    Boje KM; Wong G; Skolnick P
    Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
    Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
    Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of d-cycloserine in rats: the role of anxiety level.
    Ho YJ; Hsu LS; Wang CF; Hsu WY; Lai TJ; Hsu CC; Tsai YF
    Brain Res; 2005 May; 1043(1-2):179-85. PubMed ID: 15862531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
    Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute or prolonged exposure to 1-aminocyclopropanecarboxylic acid protects spinal neurons against NMDA toxicity.
    Lin Y; Long JB
    Eur J Pharmacol; 1996 Dec; 318(2-3):491-6. PubMed ID: 9016943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.